Search clinical trials for: G-PUR® 1x 2.0 g oral suspension

Total 58 results

Glock Health, Science and Research GmbH

Completed

G-PUR® for Reduced Lead Bioavailability

Lead Exposure

Austria
Glock Health, Science and Research GmbH

Unknown

G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Austria
Glock Health, Science and Research GmbH

Terminated

G-PUR® for Reduced Dietary Fumonisin Bioavailability

Reduction of Dietary Fumonisin Bioavailability

Austria
University of Arkansas

Not yet recruiting

Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial (COMET-GP)

Gastroparesis
ACO Hud Nordic AB
The University of Sheffield Medical School

Completed

A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier

Dermatitis, Atopic

United Kingdom
Oxford Brookes University
Roquette Freres

Completed

Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein

Healthy

United Kingdom
Jena University Hospital
German Research Foundation; Instituto Grifols, S.A.; University Hospital Goettingen and other collaborators

Recruiting

Albumin Replacement Therapy in Septic Shock (ARISS)

Septic Shock

Germany
Nestlé

Completed

Clinical Trial in Constitutional Thinness

Individuals With Constitutional Thinness

France
Retrotope, Inc.

Completed

A First in Human Study of RT001 in Patients With Friedreich's Ataxia

Friedreich's Ataxia

United States
Parc de Salut Mar

Completed

Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol

Healthy | Alcohol Consumption

Spain
LEO Pharma

Completed

An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris

Psoriasis Vulgaris

France
Coordinación de Investigación en Salud, Mexico

Completed

Gastric Per Oral Endoscopic Myotomy (G-POEM) in Refractory Gastroparesis (G-POEM)

Gastroparesis Postoperative | Gastroparesis Due to Diabetes Mellitus | Idiopathic Gastric Stasis

Mexico
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Healthy

United States
Khon Kaen University

Unknown

Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers

Pharmacokinetics of Melatonin

Thailand
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
Fresenius Kabi

Completed

Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers

Blood Glucose

Germany
Parc de Salut Mar
World Anti-Doping Agency

Completed

Dose-response Effect of Alcohol Ingestion on Steroid Profile (PROFETHYL/2)

Healthy | Alcohol Consumption

Spain
Biocodex

Recruiting

Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function (STP237)

Chronic Renal Insufficiency

Bulgaria
Sanofi

Completed

A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)

Osteoarthritis

China
LEO Pharma

Completed

A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris

Psoriasis Vulgaris

France
Aarhus University Hospital
University of Copenhagen; University of Aarhus

Completed

The Effect of Whey Protein Consumed as a Pre-meal on Postprandial Lipemia in Healthy and Subjects With Type 2 Diabetes (PREMEAL 3)

Healthy | Type 2 Diabetes
Boehringer Ingelheim

Completed

Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis

Osteoarthritis
Dompé Farmaceutici S.p.A
Cross Research S.A.

Completed

Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup

Bronchitis

Switzerland
Laboratorios Andromaco S.A.

Completed

Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)

Pharmacokinetics | Hormone Deficiency

Chile
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Preoperative Oral Antibiotics With vs Without Mechanical Bowel Preparation to Reduce Surgical Site Infections Following Colonic Resection: an International Randomized Controlled Trial. (ORALEV2)

Wounds and Injuries | Surgery--Complications

Spain, Italy, China, Greece, Russian Federation, United Kingdom
AstraZeneca

Completed

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) (ECLIPSEIII)

Hypertriglyceridemia

United States
Alcon Research

Completed

Patient Preference Comparison of AZARGA Versus COSOPT

Ocular Hypertension | Open-Angle Glaucoma
Teva Neuroscience, Inc.

Completed

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients (ENCORE)

Multiple Sclerosis
Assistance Publique Hopitaux De Marseille

Unknown

Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy (G-POEM)

Gastroparesis

France
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).

Relapsing Remitting Multiple Sclerosis
Hospital Universitari Vall d'Hebron Research Institute

Completed

Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis (ORALEV)

Surgical Wound Infection

Spain
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Tolerability of Glatiramer Acetate (GLACIER)

Relapsing-Remitting Multiple Sclerosis

United States
Aga Khan University

Unknown

Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants

Sepsis | Bacterial Infection | Infant, Newborn

Pakistan
IBSA Institut Biochimique SA

Completed

Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis

Osteoarthritis, Knee

Czech Republic, France, Germany, Italy, Slovakia, Switzerland
Celgene

Terminated

A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer

Stage IV (Metastatic) Breast Cancer

United States
University of Melbourne
Radboud University Medical Center; Sunnybrook Health Sciences Centre; UMC Utrecht and other collaborators

Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial (SNAP)

Staphylococcus Aureus Bacteremia

Australia, New Zealand, Canada, Singapore, Netherlands, Israel
Takeda
Takeda Development Center Americas, Inc.

Recruiting

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases (PID)

United States
Emzor Pharmaceutical Industries Limited

Not yet recruiting

Bioequivalence Study of Sulfadoxine/ Pyrimethamine Dispersible Tablets in Healthy Subjects Under Fasting Conditions

Bioequivalence
MEDSI Clinical Hospital 1, ICU

Recruiting

Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria

Respiratory Tract Infections | Pneumonia | Sepsis | Critical Illness | Respiratory Distress Syndrome | Pneumonia, Ventilator-Associated | Bloodstream Infection

Russian Federation
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Small Cell Lung Cancer | Solid Tumor | Non-small Cell Lung Cancer
Grifols Therapeutics LLC

Completed

Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Macular Degeneration

Germany
Grifols Therapeutics LLC

Completed

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

Purpura, Thrombocytopenic, Idiopathic

United States
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
Grifols Therapeutics LLC

Completed

Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ICE)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

United States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
Grifols Therapeutics LLC

Completed

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (PRIVIG)

Multiple Sclerosis, Relapsing-Remitting

Canada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
St. Jude Children's Research Hospital

Active, not recruiting

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Rhabdomyosarcoma

United States
Kaohsiung Veterans General Hospital.

Completed

Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy

Helicobacter Pylori Infection

Taiwan

Search clinical trials for: G-PUR® 1x 2.0 g oral suspension

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations